Form 4: Murphy USA Director Turner Reports Accrual of Dividend Equivalent Units
SEC Form 4 Filing
Director Rosemary Turner reports the accrual of dividend equivalent units related to restricted stock units (RSUs) in Murphy USA Inc.
Summary
- Rosemary Turner, a director of Murphy USA Inc., filed a Form 4 on September 9, 2024, reporting transactions related to dividend equivalent units.
- The transactions involve the accrual of dividend equivalent units on outstanding restricted stock units (RSUs) granted to Turner under the 2013 Stock Plan for Non-employee Directors and the 2023 Omnibus Plan for Non-employee Directors.
- These dividend equivalent units represent the right to receive one share of common stock, subject to the terms and conditions applicable to the corresponding RSUs.
- The reported transactions occurred on September 5, 2024, and involve the accrual of 0.699, 0.537, and 0.391 dividend equivalent units related to RSUs granted on February 10, 2022, February 9, 2023, and February 15, 2024, respectively.
- Turner has elected to defer settlement of restricted stock units and accrued dividend equivalent units until termination of service from the Board.
- Following the reported transactions, Turner beneficially owns 10.232, 4.831, and 1.285 dividend equivalent units related to the respective RSU grants.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing and does not convey any particularly positive or negative sentiment. It simply reports transactions related to director compensation.
Future Outlook
The reporting person has elected to defer settlement of restricted stock units and accrued dividend equivalent units, in accordance with their deferral election form, to the reporting person's termination of service form the Board.
Industry Context
This filing is a routine disclosure related to director compensation and equity ownership in Murphy USA. It reflects standard practices for compensating non-employee directors with equity-based awards.
Stakeholder Impact
- The accrual of dividend equivalent units has a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 09/05/2024 | Date of dividend equivalent units accrual |
| 09/09/2024 | Date of Form 4 filing |
| 02/10/2022 | Date of RSU grant related to dividend equivalent units |
| 02/09/2023 | Date of RSU grant related to dividend equivalent units |
| 02/15/2024 | Date of RSU grant related to dividend equivalent units |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.